Aurinia Pharmaceuticals Inc. (AUPH)
Aurinia Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Victoria, Canada.
Address
#140, 14315 - 118 AVENUE
EDMONTON, A0 T5L 4S6
Founded
1993
Number of Employees
300
Website
http://www.auriniapharma.com
Buyback
| Buyback Data | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $ Amount Purchased ($ in 000s ) |
- | - | - | - | - | - | - | - | - | - | $18,363 | $18,363 |
| Average Price | - | - | - | - | - | - | - | - | - | - | $5.36 | $5.36 |
| # Shares Purchased | - | - | - | - | - | - | - | - | - | - | 3,422,930 | 3,422,930 |
| Buyback Performance | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Return to Date | - | - | - | - | - | - | - | - | - | - | 30.5% | 30.5% |
| S&P 500 Return to Date | - | - | - | - | - | - | - | - | - | - | 7.4% | 7.4% |
| Excess Total Return | - | - | - | - | - | - | - | - | - | - | 23.1% | 23.1% |
| Quartile Rank |
|
|
|
|
|
|
|
|
|
|
|
|
| Percentile Rank | - | - | - | - | - | - | - | - | - | - | 89% | 61% |
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)
Never miss an email alert when insiders at AUPH make a trade.
Creating a free account takes less than one minute